Hardly crippling to drug companies but rather to executive bonuses and share price.

Most of the basic research is carried out by universities and given to drug companies for little or no cost. Drug trials in Canada have declined dramatically as the industry moves to offshore them through third parties to save money.

Altogether an unsavoury business concerned solely with maximizing profit.